Levdobutamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Levdobutamine (INN; developmental code name LY-206243; also known as (S)-dobutamine) is a sympathomimetic, selective β1-adrenergic receptor agonist, and positive inotrope which was never marketed.[1][2] It is the (S)-enantiomer of dobutamine.[1]
Other namesLevodobutamine; (S)-Dobutamine; LY-206243
| Clinical data | |
|---|---|
| Other names | Levodobutamine; (S)-Dobutamine; LY-206243 |
| Drug class | Sympathomimetic; β1-Adrenergic receptor agonist; Positive inotrope |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H23NO3 |
| Molar mass | 301.386 g·mol−1 |
| 3D model (JSmol) | |
| |
| |